244
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Insight into the interactions of fullerenes with biological membranes through molecular dynamics simulations

, , &
Article: 2350160 | Received 30 Jan 2023, Accepted 26 Apr 2024, Published online: 10 May 2024
 

ABSTRACT

This paper reviews our current understanding of how fullerene molecules interact with biological membranes. First, we discuss how fullerenes permeate into biological membranes. Next, the putative mechanisms of fullerene aggregation and dispersion within lipid bilayers are discussed along with their potential toxic effect on biological membranes. Finally, current trends in the study of fullerene-membrane interactions are highlighted as well as future challenges that need to be overcome to further advance the field.

Graphical Abstract

Abbreviations

C60=

Buckminsterfullerene

MD=

Molecular Dynamics

CG=

Coarse – grained

PMF=

Potential of Mean Force

NMR=

Nuclear Magnetic Resonance

ROS=

Reactive Oxygen Species

DPPC=

Dipalmitoyl – Phosphatidylcholine

DMPC=

Dimyristoyl – Phosphatidylcholine

DOPC=

Dioleoyl – Phosphatidylcholine

DLPC=

Dilauroyl – Phosphatidylcholine

DSPC=

Distearoyl – Phosphatidylcholine

DFPC=

Dioctadecatrienoyl – Phosphatidylcholine

DAPC=

Diarachidoyl – Phosphatidylcholine

DVPC=

Divaleryl – Phosphatidylcholine

DUPC=

Dilinoleoyl – Phosphatidylcholine

POPC=

Palmitoyloleoyl – Phosphatidylcholine

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was financially supported by National Research Council of Thailand (NRCT) through the Research Grants for Talented Mid-Career Researchers [grant number N41A640080] and Kasetsart University Research and Development Institute, KURDI, through Fundamental Fund [grant number FF(KU)33.67]. N.N. and J.W. are supported by the National Science Research and Innovation fund (NSRF) via the Program Management Unit for Human Resources & Institutional Development Research and Innovation [grant number B13F660122 and B42G670041]. C.D. is supported by the National Institute of General Medical Health under grant no. [1R15GM148982-01].